LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer files initial beneficial ownership statement (Form 3)

PUBT · 1d ago
LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer files initial beneficial ownership statement (Form 3)
  • LB Pharmaceuticals filed a Form 3 naming Susan Gani Kozauer as chief medical officer, dated Sept. 14, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002150267-26-000003), on September 24, 2026, and is solely responsible for the information contained therein.